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Abstract
Objectives: Maternal infection during pregnancy increases risk of severe neuropsychiatric disorders, including schizophrenia
and autism, in the offspring. The most consistent brain structural abnormality in patients with schizophrenia is enlarged
lateral ventricles. However, it is unknown whether the aetiology of ventriculomegaly in schizophrenia involves prenatal
infectious processes. The present experiments tested the hypothesis that there is a causal relationship between prenatal
immune challenge and emergence of ventricular abnormalities relevant to schizophrenia in adulthood.
Method:We used an established mouse model of maternal immune activation (MIA) by the viral mimic PolyI:C administered
in early (day 9) or late (day 17) gestation. Automated voxel-based morphometry mapped cerebrospinal fluid across the
whole brain of adult offspring and the results were validated by manual region-of-interest tracing of the lateral ventricles.
Parallel behavioral testing determined the existence of schizophrenia-related sensorimotor gating abnormalities.
Results: PolyI:C-induced immune activation, in early but not late gestation, caused marked enlargement of lateral ventricles
in adulthood, without affecting total white and grey matter volumes. This early exposure disrupted sensorimotor gating, in
the form of prepulse inhibition. Identical immune challenge in late gestation resulted in significant expansion of 4th
ventricle volume but did not disrupt sensorimotor gating.
Conclusions: Our results provide the first experimental evidence that prenatal immune activation is an environmental risk
factor for adult ventricular enlargement relevant to schizophrenia. The data indicate immune-associated environmental
insults targeting early foetal development may have more extensive neurodevelopmental impact than identical insults in
late prenatal life.
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Introduction
The aetiology of complex neurodevelopmental brain disorders
such as schizophrenia and autism is unknown. Epidemiological
evidence strongly suggests that maternal infection during prenatal
life may contribute to an increased risk of schizophrenia or autism in
the offspring [1–7] and exposure to prenatal infection has been
recently linked to specific neuropathological changes in schizophre-
nia [8]. A causal relationship in this epidemiological link has
received considerable support from several experimental models of
prenatal infection and/or immune activation. A multitude of
behavioural, cognitive and pharmacological abnormalities has been
detected in adult mice and rats following prenatal or neonatal
exposure to viral pathogens [9–15], the viral mimic polyriboino-
sinic–polyribocytidilic acid (PolyI:C) [16–22], the bacterial endo-
toxin lipopolysaccharide (LPS) [23,24] and the pro-inflammatory
cytokine interleukin (IL)-6 [25,26]. The most prevalent hypothesis
suggests that infection-induced disruption of prenatal or early
postnatal brain development predispose the offspring to long-lasting
changes in subsequent brain and behavioural development and
ultimately leads to adult neuropathology and associated behavioural
changes in adolescence or early adulthood [25,27].
Schizophrenia is associated with significant, progressive brain
morphological changes which become evident by early adulthood
[28]. Ventricular enlargement is the most consistently replicated
finding in patients with schizophrenia [29] and is already present
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by first clinical presentation of illness and before exposure to anti-
psychotic medication [30]. Cannon and colleagues [31] found that
ventricular enlargement and associated reductions in white matter
and subcortical volumes were unique to the clinical phenotype of
schizophrenia. That is, ventricular enlargement in patients is
thought to be due to primary causative factors not shared by
relatives with some shared genetic risk. Genetic model fitting on
twin and sibling data indicates that ventricular enlargement in
schizophrenia is driven by individual-specific environmental
influences [32] and patients with largest ventricles have also been
shown to have poor prognosis [33,34]. Considering the known
impact of prenatal infection on schizophrenia risk, the specificity of
ventriculomegaly to the clinical illness and the suggested
environmental influences on ventricular enlargement in this
disorder, maternal infection during pregnancy may represent a
significant environmental risk factor of ventricular enlargement in
the offspring. However, direct evidence for this hypothesis is still
missing. Examination of prenatal immune activation effects on
ventricular abnormalities and associated schizophrenia-related
dysfunctions in adult life is clearly warranted.
Therefore, the present study was designed to test the hypothesis
that there is a causal relationship between prenatal immune
challenge and changes in ventricular size in the adult offspring.
We used a well established mouse model of maternal immune
activation (MIA) by the viral mimic PolyI:C, which induces a
cytokine-associated viral-like acute phase response in mammalian
organisms [35]. Prenatal PolyI:C exposure in mice and rats is known
to induce a wide spectrum of brain and behavioral dysfunctions
implicated in schizophrenia and/or autism (for a review see [36]).
Interestingly, recent experimental investigations using the PolyI:C
model of MIA have highlighted that the precise timing of MIA is a
critical determinant of the specificity of the long-term brain and
behavioral pathology emerging in the offspring [36–38]. This
parallels the human epidemiological findings that the strength of the
association between prenatal infection and adult psychotic disorders
appears to be critically influenced by the precise timing during
prenatal life. In contrast to the data obtained by initial retrospective
epidemiological research designs [39–42], recent epidemiological
studies using serologic markers of maternal infection suggest that
infections during the early stages of pregnancy (i.e. in the first
trimester of human pregnancy) have a stronger impact on
schizophrenia risk in the offspring compared to second or third
trimester infections [1,43–45]. However, it is unknown whether a
postulated neurodevelopmental impact of early versus middle/late
prenatal infections on ventricular abnormalities in later life would
show a similar temporal dependency.
In order to directly address this issue, we compared the effects of
MIA in early (gestation day [GD] 9) and late (GD17) gestation on
ventricular abnormalities in the offspring. We adopted an in-vivo
volumetric magnetic resonance imaging (MRI) approach to help
surmount some of the difficulties associated with ex-vivo analyses.
For example, ex-vivo analyses using perfusion-fixation can chem-
ically alter intracellular and extracellular fluid dimensions and
subsequent histological processing causes tissue dehydration and
mechanical deformation [46]. The in-vivo method also has the
advantage of allowing further live testing of the animal after
scanning [47,48]. Here, we used 2 complementary MRI analyses
methods. First we describe the application of automated voxel-
based morphometry (VBM) to map the volume of cerebrospinal
fluid (CSF) across the whole brain. VBM relies on intensity based-
segmentation of brain into distinct tissue classes (namely, grey
matter, white matter and CSF) creating tissue class maps for
independent, rapid, and exploratory analysis of every volume-
element of brain. Recently, VBM has been applied to the ex-vivo
study of a mouse model of Huntington’s disease [49]. In the
present study we propose rapid in-vivo scanning for VBM analysis
of CSF volume in the MIA mouse model, using segmentation
techniques that do not require priori information but instead use
manual region-of-interest (ROI) tracing of the lateral ventricles to
confirm VBM findings. We predicted that, in addition to the
behavioural phenotype, early MIA would be ‘worse’ than later
MIA in terms of gross brain anatomical disruption leading to
ventricular enlargement.
Results
Early but not late prenatal immune challenge leads to
enlarged lateral ventricles in adulthood
The volumetric analyses of in-vivo MRI data showed that
prenatal immune activation in early (GD9) or late (GD17)
gestation did not significantly change total brain volume
(F(2,19) = .162, p,.851), grey matter (F(2,19) = .017, p,.98) or white
matter volume (F(2,19) = .136, p,.87) relative to prenatal control
treatment. However, the application of VBM to map the volume
of CSF showed greater CSF volumes in the lateral ventricles of
offspring exposed to MIA on GD9 compared to control offspring
(Figure 1). Importantly, the impact of prenatal immune challenge
on CSF volumes in the lateral ventricles was clearly restricted to
MIA in early gestation because no significant changes in lateral
ventricular CSF volumes were apparent in offspring exposed to
MIA in late gestation (i.e., on GD17) relative to controls
(Figure 1). Instead VBM indicated an expansion in 4th ventricle
volume in offspring exposed to prenatal challenge in late gestation.
ANOVA of region of interest measures supported this effect of
prenatal treatment on lateral ventricle volume (F(2,19) = 5.39,
p,.01) and subsequent post-hoc analyses confirmed lateral
ventriculomegaly in offspring exposed to MIA on GD9 relative
to control offspring (see Tables 1, 2 and Figure 1).
Early but not late prenatal immune challenge disrupts
sensorimotor gating in adulthood
In this test, a reduction of startle reactivity to the pulse stimulus
on prepulse-plus-pulse trials relative to pulse-alone trials consti-
tutes the PPI effect. The analysis of percent PPI (% PPI) confirmed
that offspring exposed to MIA on GD9 but not on GD17 displayed
reduced sensorimotor gating relative to control offspring
(Figure 2). A 36363 (group6prepulse intensity6pulse intensity)
repeated measures ANOVA showed a significant effect of prepulse
intensity [F(2, 131) = 11.87, p,0.0001] and a significant group
difference in %PPI [F(2, 131) = 3.56, p,0.05]. There was also a
significant interaction between pulse intensity and group [F(4,
262) = 4.32, p,0.01]. Subsequent post-hoc tests verified that the
overall group difference in %PPI was driven by a significant
impairment in PPI in the GD9 PolyI:C compared to control group
(p,0.05). This PPI deficit in GD9 PolyI:C animals was evident in
the pulse 100 and pulse 120 conditions (p,0.05). There was no
difference in %PPI between GD17 PolyI:C and control groups
(Figure 2). There were no significant group differences in startle
reactivity, startle habituation or prepulse-elicited reactivity (data
not shown). Hence, the PPI attenuating effects of prenatal PolyI:C
exposure in early gestation cannot be accounted for by changes in
general startle reactivity and/or prepulse detection, reflecting a
genuine disruption of sensorimotor gating.
Discussion
The present study provides the first piece of evidence supporting
the hypothesis that prenatal immune activation may be a relevant
Prenatal Risk in Schizophrenia
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environmental risk factor for ventricular enlargement in adult-
hood. Using an experimental model of MIA by the viral mimic
PolyI:C, our results demonstrate a casual relationship between
maternal exposure to a viral-like acute phase response during early
gestation and the subsequent emergence of enlarged lateral
ventricles in the adult offspring. Importantly, this relationship
appears to be clearly restricted to prenatal immunological insults
taking place during early foetal development. This is because no
Table 1. Mean volumes of lateral ventricles and tissue compartments.
Group Grey White G/W Total Brain Volume Left Ventricle Right Ventricle L/WBV R/WBV
(mm3) (mm3) (mm3) (mm3) (mm3)
Control 188.3615.0 127.0612.8 1.50 330.469.9 2.446.24 2.436.28 0.0074 0.0074
GD9 189.7616.1 124.9610.5 1.54 328.668.4 2.756.46 2.806.37* 0.0084 0.0085 {
GD17 188.9614.7 128.1612.6 1.49 331.166.3 2.386.38 2.256.32 0.0072 0.0068
Main tissue compartment volumes and lateral ventricular volumes6Standard Deviation are shown. G/W, ratio of total grey matter to white matter tissue volumes; L/
WBV, ratio of left ventricle region-of-interest volume to whole brain volume; R/WBV ratio of right ventricle region-of-interest to whole brain volume.
*Significant difference of Right Ventricle between GD9 and controls (p,.036 two-tailed).
{Significant difference of R/WBV between GD9 and controls (p,.047 two-tailed).
doi:10.1371/journal.pone.0006354.t001
Figure 1. CSF space quantified using VBM and ROI methodology. a. Overlap in lateral ventricles quantified using voxel-based morphometry
(VBM) and region-of-interest (ROI) methodology showing an animal with the lowest agreement (Dice = 0.92 both sides) between the manual
delineation and automatic segmentation of ventricles. Left ventricle in grey; right ventricle in white. b. Region-of-Interest defined lateral ventricles.
Raw images and the 3D rendered lateral ventricles of a mouse from the control and one from the GD9 group. c. Voxel-wise analyses of CSF in adult
mice exposed to prenatal challenge at GD9 compared to control and GD17 compared to control. Red indicates a significantly greater likelihood of
finding CSF; Blue indicates a significantly lower likelihood of finding CSF.
doi:10.1371/journal.pone.0006354.g001
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significant changes in lateral ventricular size were apparent in
offspring exposed to MIA in late gestation (Figure 1). Hence,
prenatal immune challenge in early gestation has a greater impact
on the development of lateral ventricular abnormalities compared
with immune activation at late stages of pregnancy. Our parallel
behavioral analysis further confirmed that MIA in early gestation
leads to a wider spectrum of schizophrenia-related abnormalities
in the adult offspring compared to identical MIA in late gestation:
Adult mice prenatally exposed to PolyI:C on GD9 displayed PPI
deficits whereas offspring subjected to PolyI:C exposure on GD17
did not. Together, our findings support the hypothesis that early
prenatal immune activation in general, and exposure to a viral-like
acute phase response in particular, exert a more extensive
neurodevelopmental impact in terms of schizophrenia-related
brain and behavioral abnormalities compared with immunological
insults taking place later in gestation.
The early and late gestational windows selected in the present
study (i.e., GD9 and GD17 in the mouse) correspond roughly to
the middle of the first and second trimester of human pregnancy
respectively [50]. Hence, when extrapolating the present findings
to human epidemiological data, our results corroborate recent
epidemiological studies using serologic verification of the maternal
infection to suggest that infections during the early stages of
pregnancy (i.e. in the first trimester of human pregnancy) are
associated with the highest risk of schizophrenia and related
disorders [1,3,43–45,51]. We acknowledge that prenatal immune
activation is not the only possible cause of ventricular enlargement,
and other rodent models of schizophrenia have shown ventricular
enlargement [52]. However, we believe the present experiments
do highlight the importance of immune exposure in what is a
multifactorial and complex condition. A clear relationship between
prenatal infection and risk of ventricular enlargement in
schizophrenia has not been established yet in human literature.
The present experimental findings may therefore serve to
encourage further exploration of possible infectious aetiologies of
ventricular abnormalities in schizophrenia and related disorders.
In an elegant study fractionating the contribution of individual
cytokines to the behavioural phenotype following MIA, Smith and
co-workers [26] found IL6 was a key trigger to neurodevelop-
mental disruption. In addition to its role in inflammation, IL6
activates the JAK-STAT signal cascade which has an important
role in embryonic development, neurogenesis and gliogenesis
[53,54]. Interestingly, the IL6 receptor is highly expressed in the
ganglionic eminence (GE) of the germinal cells lining the
ventricles. This germinal layer gives rise to neurons and glia
during early and mid fetal life and the GE component contains the
precursor cells of the striatum and lasts much longer than other
proliferative zones of the embryonic brain [55]. It is therefore
postulated that activation of the IL6-R of the immature cells of the
Table 2. Voxel-wise comparison of GD9 and GD17 MIA mice with controls.
Location Cluster Size (mm3) Z score p value Co-ordinates (mm)
X Y Z
GD9.Control
Left Lateral Ventricle 0.37 3.11 .001 20.88 20.48 22.64
Right Lateral Ventricle 0.18 2.84 .002 0.96 20.96 21.84
Control.GD9
Third Ventricle 0.22 3.73 .000 0.00 20.32 23.12
Cerebral Aqueduct 0.13 3.04 .001 20.08 24.96 22.8
Fourth Ventricle 0.26 2.95 .002 20.24 25.92 24.08
Third Ventricle 0.08 2.85 .002 20.08 21.44 26.32
GD17.Control
Fourth Ventricle 0.33 3.39 .000 0.24 26.48 23.68
Control.GD17
Right Lateral Ventricle 0.29 3.68 .000 0.8 0.72 23.6
Left Lateral Ventricle 0.10 3.07 .001 23.36 22.16 24.32
Right Lateral Ventricle 0.17 2.98 .001 1.84 21.2 21.68
X, Y, Z co-ordinates are based on the Lambda-Bregma system in the Allen mouse brain atlas. Cluster Size = 0.0768 mm3.
doi:10.1371/journal.pone.0006354.t002
Figure 2. Prepulse inhibition of startle. Behavioral tests in mouse
exposed to maternal immune activation at gestation day 9 or 17 (GD9
POL; GD17 POL) compared to controls (CON). Prepulse inhibition of
startle (PPI). % PPI = (pulse-alone - prepulse-plus-pulse)/pulse-
alone6100%. A gradual increase in the amount of inhibition was
observed as a function of the increasing intensity of the prepulse
stimulus. All values are means6SEM.
doi:10.1371/journal.pone.0006354.g002
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periventricular zone in early fetal life somehow alters the
development and migration of neurons particularly in the
striatum, and hence impacts upon the surrounding ventricular
space. This is consistent with evidence pointing to disorder of
neuronal migration in schizophrenia [56–58], disrupted connec-
tivity in schizophrenia [59,60] and striatal and ventricular
morphological differences in schizophrenia [29,30,61,62]. Further
evidence that the germinal matrix is especially vulnerable to
inflammatory mediators comes from observations of subependy-
mal cysts at the head of the caudate following congenital rubella
infection [63]. As mentioned earlier, prenatal rubella infection is
strongly associated with schizophrenia [1] and subependymal cysts
have also been reported in children with autism who had
congenital infection [64].
Our results raise a question about the relevance of late
pregnancy MIA to neurodevelopmental disorders. At first glance
the absence of ventricular enlargement in GD17 mice appears to
shifts the specificity of this exposure away from schizophrenia at
least. However, prenatal exposure of mice to human influenza
virus on GD18 alters the expression of genes associated with
schizophrenia and autism such as Sema3a, Trfr2 and Vldlr [65]
and both GD9 and GD18 exposures cause up-regulation of the
transcription factor Foxp2 [65,66] which has been linked with
schizophrenia [67] and autism [68]. Therefore one explanation of
these findings is that the effect of MIA at GD17 is indeed simply
milder than at GD9 [36], that this exposure is sufficient to cause
some but not all of the neurodevelopmental phenotype relevant to
schizophrenia.
Another possible explanation is that the outcome of MIA on
GD17 translates to a different subtype of schizophrenia. Patients
with schizophrenia may be categorized on the basis of their
memory deficits and associated brain morphology [69]. Those
with primarily encoding/storage difficulties or ‘cortical’ pattern
deficits are in the minority and have isolated temporal lobe
pathology. The majority have a ‘subcortical’ pattern of retrieval
difficulties associated with ventricular enlargement and frontal
grey matter reductions [69]. Relevant to this discussion are our
previous results [38] showing impaired spatial working memory in
mice exposed to MIA on GD17, not GD9. Spatial working
memory depends upon intact temporal lobe circuits [70,71], thus
the GD17 mice appear to have a degree of commonality with the
‘cortical’ subgroup of patients with schizophrenia who have
‘working’ memory deficits, but no ventricular enlargement. In
contrast the GD9 group with enlarged ventricles fits the
subcortical or fronto-striatal schizophrenia phenotype described
by Turetsky and colleagues [69] or the psychotic cohort with
enlarged ventricles sampled in the study by Cannon et al [31]. A
PPI impairment restricted to the GD9 ‘ventricular enlargement’
group also fits well with the evidence that sensorimotor gating has
a strongly frontal-striatal basis [72–74]. Indeed the PPI impair-
ment in schizophrenia has recently been shown to correlate with
lower grey matter volumes in dorsolateral prefrontal, middle
frontal and the orbital/medial prefrontal cortices [75] and is
associated with activation abnormalities in fronto-striatal circuits
[72]. Unfortunately it is not known if patients with schizophrenia
categorized on the basis of memory impairment can also be
distinguished on the basis of PPI impairment, but a prediction that
this minority of ‘cortical’ patients have less PPI impairment, would
be interesting to test.
Complicating this interpretation is the issue of autism. Autism
has been suggested to lie on the same spectrum as schizophrenia
with individuals with schizotypy also having a significant number
of autistic traits [76]. People with autism spectrum have a strong
family history of schizophrenia and bipolar disorder [77] and some
children with autism go on to develop schizophrenia in later life.
People with Asperger’s syndrome have higher scores on measures
of paranoia than healthy controls [78] and ‘negative’ symptoms in
Asperger’s syndrome appear to respond to the antipsychotic
risperidone [79]. Together these overlapping observations support
the possibility that autism disorders and schizophrenia share causal
influences. Although PPI is generally thought to be disrupted in
higher functioning individuals with autism spectrum [80,81],
others have found limited evidence for sensorimotor gating
abnormalities in a broader sample of ages and abilities [82]. The
mice exposed to MIA at GD 17 without PPI deficits therefore
appear to better reflect the cohort in this latter study.
The VBM analysis generated an unpredicted effect of late MIA
on 4th ventricle volume. This would not have been identified from
a ROI analysis alone and highlights the advantage of a whole-
brain analytic method in uncovering unexpected, fresh informa-
tion. What exactly 4th ventricular enlargement following late MIA
means will be important to explore. An adjacent loss of regional
cerebellar volume might contribute to this result and discrete
regions of the cerebellar vermis have been reported to be smaller
in schizophrenia despite no overall difference in cerebellar volume
[83]. The evidence for cerebellar abnormalities in autism spectrum
is extensive and convincing [84–88], and changes are likely to be
progressive [89,90]. Potentially the timing of a prenatal event,
either genetic or environmental or indeed epigenetic, critically
influences phenotypic outcome along a schizophrenia-autism
spectrum in later life. Our future work will focus on validating
the segmentation of other tissue class compartments segmented in
VBM in order to map the full impact of prenatal immune
challenge at different time points on brain structure and its
relevance to specific neurodevelopmental disorders.
The in-vivo scanning design adopted in our study offered a
number of other advantages. It meant that behaviour and brain
structure could be characterized in the same cohort of animals.
However, since the behaviour testing could potentially modulate
brain and the procedures involved in MRI, including prolonged
anesthetic exposure, might influence behaviour testing, we
conducted the PPI study in animals with and without MRI. In
addition, we avoided confounding effects of fixation and histology
approaches on ventricular morphometry with in-vivo MRI. The
novel application of VBM methods to map the in-vivo CSF space in
the mouse was validated using manual ROI measurement of the
lateral ventricles and we believe the in-vivo technique holds
particular promise for the study of longitudinal changes during
evolution of the disease process. Conventional anti-psychotic and
anti-depressant drug treatment prevents the behavioural impact of
early MIA [91] and we are now looking at whether ventricular
enlargement can also be halted by drug treatment. The VBM
analysis methods adopted here add to the potential for rapid
throughput of such studies.
A disadvantage of our study is that resource constraints meant
that the numbers included were modest, but supplementing the
VBM approach with a manual ROI quantification of ventricular
volume lends considerable confidence that the effects seen are
robust. Lastly, we included only male animals in our study and we
cannot say for certain that the results can be extrapolated to
females. There is good evidence that ventricular enlargement in
schizophrenia is actually greater in females than males with the
condition [92] and, as the MIA behavioural phenotype is observed
in both male and female offspring [38], we think it is likely that
similar ventricular enlargement would be present in the female
offspring. Future studies will address the issue of gender.
In conclusion, we show dramatic differences in brain ventricular
morphometry in mice exposed to a brief, non-specific immune
Prenatal Risk in Schizophrenia
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challenge during early life in utero. We report that the earlier the
exposure the poorer the outcome in terms of both behaviour and
brain morphometry. The current experiments do not tell us whether
the ventricular changes observed are caused directly or indirectly.
We suspect they may be an indirect consequence of regional
changes in periventricular structures and our on-going studies will
explore this in detail. Thus our work provides strong impetus for
further investigation of the role of prenatal immune mechanisms in
the pathogenesis of schizophrenia and related disorders because
such effects are potentially modifiable. It encourages the application
of complementary imaging and behavioural techniques to search for
causal mechanisms and new treatments in these poorly understood
neurodevelopmental disorders.
Materials and Methods
Animals
Female and male C57BL6/N were bred and mated by The
University of Hong Kong, Laboratory Animal Unit, (LAU).
Timed-pregnant mice were held in a 12:12 h reversed light-dark
cycle (lights on at 19:00), and temperature and humidity-
controlled (2161uC, 5565%) animal vivarium. Animals were
maintained under ad libitum food and water diet supplied by the
LAU. All experiments were approved by the Committee on the
Use of Live Animals in Teaching and Research at The University
of Hong Kong and every effort was made to minimize the number
of animals used and their suffering.
Prenatal treatment
This followed the procedures previously reported [16,17,37].
PolyI:C (potassium salt) was obtained from Sigma Aldrich and
dissolved in saline. A dose of 5 mg/kg in an injection volume of 5 ml/
kg, prepared on the day of injection was administered to pregnant
dams on GD9 and GD17 via the tail vein under mild physical
constraint. Control animals were administered 5 ml/kg saline via tail
vein on either GD9 or GD17. The animals were returned to the
home cage after the injection. The resulting offspring were weaned
and sexed at postnatal day (PND) 21. The pups were weighed and
littermates of the same sex were caged separately, three to four per
cage. Male offspring only were used in the following experiments.
MRI
In-vivo MRI scanning took place at 12-weeks old in a 7 T scanner
with a maximum gradient of 360 mT/m (70/16 PharmaScan,
Bruker Biospoin GmbH, Germany). Animals were weighed before
scanning and were anesthetized during scanning with isoflurane/air
mixture at 3% for induction and 1.5% for maintenance via a nose
cone. A quadrature RF coil with 23 mm inner diameter was used. A
set of scout images [T2 – weighted: Effective TE = 38.71 ms,
TR = 4614.566 ms, No of Average = 6, Rare Factor = 8, Acquisition
Matrix = 2566256, FOV = 25625 mm, Slice thickness = 0.25 mm,
Scan Time = 11 m4 s] in axial orientation were acquired in each
animal. This sequence took less than one hour. Preliminary analysis
indicated no difference between animals exposed to saline on GD9
(n = 3) or GD17 (n = 5) therefore these mice were combined in a
single control group. The final numbers in MRI study were:
controls = 8, PolyI:C = 14 (PolyI:C, GD9 = 8, GD17 = 6).
Region of interest (ROI) measurement
Manual measurements were done using InsightITK-Snap
(http://www.itksnap.org/) by a single rater (WR), blind to subject
group membership. Total brain volume was measured from a
mask that delineates brain tissue from the skull, generated by the
semi-automatic, region growing ‘‘3D-snake’’ method. Each of the
masks was manually edited for any miscoverage. Lateral ventricles
were delineated according to previously described boundaries and
landmarks [93]. Voxels within the region of interest were
highlighted slice-by-slice with the ‘‘Paint bush’’ tool. Left and
right lateral ventricles were labeled separately.
Voxel based Morphometry (VBM)
Images were preprocessed with SPM2 (http://www.fil.ion.ucl.
ac.uk/,spm/) and FSL (http://www.fmrib.ox.ac.uk/fsl/) running
on a Linux workstation. The whole preprocessing routine included
skull stripping, custom template creation, tissue classification and
normalization.
In the first step, the skull was removed from the raw image by
subtracting the brain mask created in the previous section. This
‘skull-stripped’ brain was transformed to a standard space by co-
registering to a publicly available mouse template [94] using a 12-
paramenter affine transformation [95] in SPM2. The normalized
brains of all the mice were averaged to create a custom template.
The skull-stripped image was segmented into corresponding
tissues classes using an intensity based tissue classification kernel [96]
in FSL. Since ‘a priori’ information on the probability distribution of
different tissue types was not available, the assignment of tissue
classes was based solely on voxel intensities. The kernel was set to
classify brain tissue into 5 compartments instead of the conventional
3 (grey, white and CSF) for a more refined classification. The extra
compartments captured whole brain grey matter comprising
cortical, and hippocampal formation grey matter, and whole brain
white matter comprising cortical (corpus callosum, internal capsule)
and pontine white matter. The tissue maps of the 2 grey matter and 2
white matter compartments were combined to give the more
conventional 3-class grey, white and CSF (see Figure 3).
In the last step, the skull-free brain was normalized to the
custom template using a combination of linear and non-linear
transformation [95] in SPM2. The parameters from this
transformation were applied to normalize the segmented tissue
maps from the previous step. Finally, as ventricular volumes were
the focus of the current study, the normalized CSF map was
modulated [97] and smoothed with a 0.3 mm FWHM Gaussian
kernel for analysis.
Statistical analysis was done in SPM2, using ‘‘Single-subject:
conditions & covariates’’ to compare ventriclar volume between
different groups. All results were threshold at uncorrected p,.005
(seed) and p,.05 (extension), and a minimum cluster size 150
voxels6(0.0860.0860.08) mm/voxel = 0.0768 mm3. The co-ordi-
nates of the clusters were reported according to the conventional
Lambda-Bregma system in the Allen Mouse Atlas (http://mouse.
brain-map.org/atlas/index.html).
In order to validate the segmentation reliability (i.e. to ensure that
the VBM result was not driven by misclassifications), regions of left
and right lateral ventricles from the automatic procedure were
extracted and compared to the manual ROI. The DICE similarity
co-efficient [98] was calculated to assess the degree of overlap
between manually defined ventricles and ventricles segmented using
the VBM routine where: DICE = 2 ( ROI ventricles and VBM
ventricles)/(ROI ventricles or VBM ventricles).
The lowest DICE co-efficient between VBM and ROI ventricle
measurements was 0.92, and the mean DICE co-efficient between
VBM and ROI ventricle measurements was 0.927 for left lateral
ventricle and 0.948 for right lateral ventricle indicating substantial
overlap between the 2 techniques as shown in Figure 1.
Behavioral phenotyping
Subsequent to the MRI investigations we were interested to
confirm the differential impact of early and late MIA on
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behavioral abnormalities relevant to schizophrenia and related
disorders. We assessed the effects of prenatal immune challenge in
early (GD9) or late (GD17) gestation, relative to prenatal control
treatment, on sensorimotor gating using PPI of the acoustic startle
reflex. PPI impairment has been linked to several neuropsychiatric
disorders with a presumed neurodevelopmental origin, including
schizophrenia [75,99,100] and autism [80,81]. All the animals
included in the MRI analysis were tested 1 week after MRI
scanning. To rule out any unpredictable effect of MRI on
behaviour we extended the sample to include a scan naı¨ve sample
prenatally exposed to saline or polyI:C. Behavioral testing was
conducted during the dark phase of the light-dark cycle.
Prepulse inhibition (PPI) of the acoustic startle
reflex. The procedures and testing parameters for evaluation of
PPI essentially followed those described previously [101]. In order to
exclude the effect of MRI scan on PPI test, we initially compared PPI
in a group of mice exposed to saline or polyI:C without MRI scan
with groups tested after MRI scan. The results showed no significant
effect of scan on PPI in any group (data not shown) therefore mice
with and without scan were combined. Final numbers in the PPI
experiment were: controls = 18 (8 with MRI scan, 10 without scan),
GD9 PolyIC = 13 (8 with scan, 5 without scan) and GD 17
PolyIC = 17 (6 with scan, 11 without scan). Two standard acoustic
startle chambers for mice (SR-LAB, San Diego Instruments, San
Diego, CA, USA) generated the continuous background noise of
65 dBA and white noise stimuli. Whole body response was
transformed to an analogue signal by a piezoelectric unit then
digitized and stored. At the onset of the pulse (for pulse alone or
prepulse-pulse trials) or prepulse (for prepulse alone trials) 130
readings were taken at 0.5-ms intervals (across 65 ms) and the
average amplitude (in arbitrary units) over 65 ms indicated reactivity
to the pulse or prepulse stimuli. In a test session lasting approximately
45 min a mixture of pulse-alone, prepulse-plus-pulse, prepulse-alone
and no-stimulus (background noise) trials were presented. PPI was
calculated as the reduction of startle responses in the prepulse-plus-
pulse trials relative to startle in pulse-alone trials. Pulse stimuli were
100, 110, and 120 dBA lasting 40 ms. Prepulse stimuli were 20 ms
duration of 6, 12, and 18 dBA units above background respectively
with 100 ms stimulus onset asynchrony between prepulse and pulse
stimuli on prepulse-plus-pulse trials. Animals were acclimatized for
2 min prior to the first trial. The first 6 trials were 2 pulse only trials of
each of the 3 pulse intensities to stabilize the startle response. Then
followed 10 blocks of 16 trials in pseudorandom order, each block
comprising: 3 pulse-alone trials (100, 110 or 120 dBA), 3 prepulse-
alone trials (+6, +12, or +18 dBA units above background), 9
combinations of prepulse-plus-pulse trials (3 prepulse options63 pulse
options), and 1 no-stimulus trial (ns), with a variable intertrial interval
of a mean of 15 s (10 s to 20 s). The session ended with a final block
of 6 pulse-alone trials as in the first block.
Statistical analysis
Behavioral test data was analyzed using parametric analysis of
variance (ANOVA) and analysis of covariance (ANCOVA), followed
by post-hoc Scheffe test if appropriate. Where data was not normally
distributed, the values were transformed or non-parametric testing
adopted. The criterion for statistical significance was set as p,0.05.
All analyses were conducted using the statistical software SPSS for
Windows (version 16). Behavioral and MRI indices from offspring
prenatally exposed to control saline treatment at GD9 and GD17
were not different, therefore they were combined to form a single
control group. One animal (a GD9 control which failed to thrive
postnatally) was excluded from the analyses.
Acknowledgments
The authors thank Dr K.S. Lo, Head of the Laboratory Animal Unit,
University of Hong Kong and staff of the unit for the provision of space,
facilities and expert animal husbandry. We thank the members of the
Neuroimaging Group in the Department of Psychiatry for their useful
discussion of our work. The authors declare that no conflict of interest
arises from this work.
Figure 3. Average T2 image and segmented tissue maps of all the mice used in this study.
doi:10.1371/journal.pone.0006354.g003
Prenatal Risk in Schizophrenia
PLoS ONE | www.plosone.org 7 July 2009 | Volume 4 | Issue 7 | e6354
Author Contributions
Conceived and designed the experiments: SEC PCS EXW GMM.
Performed the experiments: QL EH. Analyzed the data: QL CC RW.
Contributed reagents/materials/analysis tools: SC. Wrote the paper: JF
UM GMM.
References
1. Brown AS, Cohen P, Harkavy-Friedman J, Babulas V, Malaspina D, et al.
(2001) A.E. Bennett Research Award. Prenatal rubella, premorbid abnormal-
ities, and adult schizophrenia. Biol Psychiatry 49: 473–486.
2. Brown AS, Schaefer CA, Quesenberry CP Jr, Liu L, Babulas VP, et al. (2005)
Maternal exposure to toxoplasmosis and risk of schizophrenia in adult
offspring. Am J Psychiatry 162: 767–773.
3. Brown AS (2006) Prenatal infection as a risk factor for schizophrenia.
Schizophr Bull 32: 200–202.
4. O’Callaghan E, Sham P, Takei N, Glover G, Murray RM (1991)
Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet
337: 1248–1250.
5. Sham PC, O’Callaghan E, Takei N, Murray GK, Hare EH, et al. (1992)
Schizophrenia following pre-natal exposure to influenza epidemics between
1939 and 1960. Br J Psychiatry 160: 461–466.
6. Chess S (1971) Autism in children with congenital rubella. J Autism Child
Schizophr 1: 33–47.
7. Chess S, Fernandez P, Korn S (1978) Behavioral consequences of congenital
rubella. J Pediatr 93: 699–703.
8. Brown AS, Deicken RF, Vinogradov S, Kremen WS, Poole JH, et al. (2009)
Prenatal infection and cavum septum pellucidum in adult schizophrenia.
Schizophrenia Research 09 January 2009.
9. Fatemi SH, Earle J, Kanodia R, Kist D, Emamian ES, et al. (2002) Prenatal
viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood:
implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 22:
25–33.
10. Fatemi SH, Emamian ES, Sidwell RW, Kist DA, Stary JM, et al. (2002)
Human influenza viral infection in utero alters glial fibrillary acidic protein
immunoreactivity in the developing brains of neonatal mice. Mol Psychiatry 7:
633–640.
11. Shi L, Fatemi SH, Sidwell RW, Patterson PH (2003) Maternal influenza
infection causes marked behavioral and pharmacological changes in the
offspring. J Neurosci 23: 297–302.
12. Hornig M, Briese T, Lipkin WI (2001) Bornavirus tropism and targeted
pathogenesis: virus-host interactions in a neurodevelopmental model. Adv
Virus Res 56: 557–582.
13. Hornig M, Solbrig M, Horscroft N, Weissenbock H, Lipkin WI (2001) Borna
disease virus infection of adult and neonatal rats: models for neuropsychiatric
disease. Curr Top Microbiol Immunol 253: 157–177.
14. Lancaster K, Dietz DM, Moran TH, Pletnikov MV (2007) Abnormal social
behaviors in young and adult rats neonatally infected with Borna disease virus.
Behav Brain Res 176: 141–148.
15. Lipkin WI, Hornig M (2003) Microbiology and immunology of autism
spectrum disorders. Novartis Found Symp 251: 129–143; discussion 144–128,
281–197.
16. Meyer U, Feldon J, Schedlowski M, Yee BK (2006) Immunological stress at the
maternal-foetal interface: a link between neurodevelopment and adult
psychopathology. Brain Behav Immun 20: 378–388.
17. Meyer U, Feldon J, Schedlowski M, Yee BK (2005) Towards an immuno-
precipitated neurodevelopmental animal model of schizophrenia. Neurosci
Biobehav Rev 29: 913–947.
18. Meyer U, Murray PJ, Urwyler A, Yee BK, Schedlowski M, et al. (2007) Adult
behavioral and pharmacological dysfunctions following disruption of the fetal
brain balance between pro-inflammatory and IL-10-mediated anti-inflamma-
tory signaling. Mol Psychiatry.
19. Patterson PH (2002) Maternal infection: window on neuroimmune interactions
in fetal brain development and mental illness. Current Opinion in
Neurobiology 12: 115–118.
20. Watanabe Y, Hashimoto S, Kakita A, Takahashi H, Ko J, et al. (2004)
Neonatal impact of leukemia inhibitory factor on neurobehavioral development
in rats. Neurosci Res 48: 345–353.
21. Zuckerman L, Rehavi M, Nachman R, Weiner I (2003) Immune activation
during pregnancy in rats leads to a postpubertal emergence of disrupted latent
inhibition, dopaminergic hyperfunction, and altered limbic morphology in the
offspring: a novel neurodevelopmental model of schizophrenia. Neuropsycho-
pharmacology 28: 1778–1789.
22. Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, et al. (2006)
Immune activation during pregnancy in mice leads to dopaminergic
hyperfunction and cognitive impairment in the offspring: a neurodevelopmen-
tal animal model of schizophrenia. Biol Psychiatry 59: 546–554.
23. Romero E, Guaza C, Castellano B, Borrell J (2008) Ontogeny of sensorimotor
gating and immune impairment induced by prenatal immune challenge in rats:
implications for the etiopathology of schizophrenia. Mol Psychiatry.
24. Borrell J, Vela JM, Arevalo-Martin A, Molina-Holgado E, Guaza C (2002)
Prenatal immune challenge disrupts sensorimotor gating in adult rats.
Implications for the etiopathogenesis of schizophrenia. Neuropsychopharma-
cology 26: 204–215.
25. Samuelsson AM, Jennische E, Hansson HA, Holmang A (2006) Prenatal
exposure to interleukin-6 results in inflammatory neurodegeneration in
hippocampus with NMDA/GABA(A) dysregulation and impaired spatial
learning. Am J Physiol Regul Integr Comp Physiol 290: R1345–1356.
26. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH (2007) Maternal immune
activation alters fetal brain development through interleukin-6. J Neurosci 27:
10695–10702.
27. Gilmore JH, Jarskog LF (1997) Exposure to infection and brain development:
cytokines in the pathogenesis of schizophrenia. Schizophr Res 24: 365–367.
28. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E (2008) The
anatomy of first-episode and chronic schizophrenia: an anatomical likelihood
estimation meta-analysis. Am J Psychiatry 165: 1015–1023.
29. Chua SE, McKenna PJ (1995) Schizophrenia–a brain disease? A critical review
of structural and functional cerebral abnormality in the disorder. Br J Psychiatry
166: 563–582.
30. Chua SE, Cheung C, Cheung V, Tsang JT, Chen EY, et al. (2007) Cerebral
grey, white matter and csf in never-medicated, first-episode schizophrenia.
Schizophr Res 89: 12–21.
31. Cannon TD, van Erp TG, Huttunen M, Lonnqvist J, Salonen O, et al. (1998)
Regional gray matter, white matter, and cerebrospinal fluid distributions in
schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry 55:
1084–1091.
32. Rijsdijk FV, van Haren NE, Picchioni MM, McDonald C, Toulopoulou T, et
al. (2005) Brain MRI abnormalities in schizophrenia: same genes or same
environment? Psychol Med 35: 1399–1409.
33. Staal WG, Hulshoff Pol HE, Kahn RS (1999) Outcome of schizophrenia in
relation to brain abnormalities. Schizophr Bull 25: 337–348.
34. Staal WG, Hulshoff Pol HE, Schnack HG, van Haren NE, Seifert N, et al.
(2001) Structural brain abnormalities in chronic schizophrenia at the extremes
of the outcome spectrum. Am J Psychiatry 158: 1140–1142.
35. Traynor TR, Majde JA, Bohnet SG, Krueger JM (2004) Intratracheal double-
stranded RNA plus interferon-gamma: a model for analysis of the acute phase
response to respiratory viral infections. Life Sci 74: 2563–2576.
36. Meyer U, Yee BK, Feldon J (2007) The neurodevelopmental impact of
prenatal infections at different times of pregnancy: the earlier the worse?
Neuroscientist 13: 241–256.
37. Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, et al. (2006) The
time of prenatal immune challenge determines the specificity of inflammation-
mediated brain and behavioral pathology. J Neurosci 26: 4752–4762.
38. Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J (2008) Adult brain and
behavioral pathological markers of prenatal immune challenge during early/
middle and late fetal development in mice. Brain, Behavior, and Immunity 22:
469–486.
39. Mednick SA, Machon RA, Huttunen MO, Bonett D (1988) Adult
schizophrenia following prenatal exposure to an influenza epidemic. Arch
Gen Psychiatry 45: 189–192.
40. Suvisaari J, Haukka J, Tanskanen A, Hovi T, Lonnqvist J (1999) Association
between prenatal exposure to poliovirus infection and adult schizophrenia.
Am J Psychiatry 156: 1100–1102.
41. Limosin F, Rouillon F, Payan C, Cohen JM, Strub N (2003) Prenatal exposure
to influenza as a risk factor for adult schizophrenia. Acta Psychiatr Scand 107:
331–335.
42. Beydoun H, Saftlas AF (2008) Physical and mental health outcomes of prenatal
maternal stress in human and animal studies: a review of recent evidence.
Paediatr Perinat Epidemiol 22: 438–466.
43. Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, et al. (2004)
Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch
Gen Psychiatry 61: 774–780.
44. Babulas V, Factor-Litvak P, Goetz R, Schaefer CA, Brown AS (2006) Prenatal
exposure to maternal genital and reproductive infections and adult schizo-
phrenia. Am J Psychiatry 163: 927–929.
45. Sorensen HJ, Mortensen EL, Reinisch JM, Mednick SA (2008) Association
Between Prenatal Exposure to Bacterial Infection and Risk of Schizophrenia.
Schizophr Bull.
46. Hayat MA (2000) Principles and Techniques of Electron Microscopy:
Biological Applications.: Cambridge University Press.
47. Wolf OT, Dyakin V, Patel A, Vadasz C, de Leon MJ, et al. (2002) Volumetric
structural magnetic resonance imaging (MRI) of the rat hippocampus following
kainic acid (KA) treatment. Brain Res 934: 87–96.
48. Wolf OT, Dyakin V, Vadasz C, de Leon MJ, McEwen BS, et al. (2002)
Volumetric measurement of the hippocampus, the anterior cingulate cortex,
and the retrosplenial granular cortex of the rat using structural MRI. Brain Res
Brain Res Protoc 10: 41–46.
49. Sawiak SJ, Wood NI, Williams GB, Morton AJ, Carpenter TA (2009) Voxel-
based morphometry in the R6/2 transgenic mouse reveals differences between
genotypes not seen with manual 2D morphometry. Neurobiol Dis 33: 20–27.
Prenatal Risk in Schizophrenia
PLoS ONE | www.plosone.org 8 July 2009 | Volume 4 | Issue 7 | e6354
50. Clancy B, Kersh B, Hyde J, Darlington RB, Anand KJ, et al. (2007) Web-based
method for translating neurodevelopment from laboratory species to humans.
Neuroinformatics 5: 79–94.
51. Rehn AE, Rees SM (2005) Investigating the neurodevelopmental hypothesis of
schizophrenia. Clin Exp Pharmacol Physiol 32: 687–696.
52. Torres G, Meeder BA, Hallas BH, Spernyak JA, Mazurchuk R, et al. (2005)
Ventricular size mapping in a transgenic model of schizophrenia. Brain Res
Dev Brain Res 154: 35–44.
53. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, et al.
(2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
Biochem J 374: 1–20.
54. Zhao B, Schwartz JP (1998) Involvement of cytokines in normal CNS
development and neurological diseases: recent progress and perspectives.
J Neurosci Res 52: 7–16.
55. Kostovic I, Judas M (1998) Transient patterns of organization of the human
fetal brain. Croat Med J 39: 107–114.
56. Bunney BG, Potkin SG, Bunney WE Jr (1995) New morphological and
neuropathological findings in schizophrenia: a neurodevelopmental perspec-
tive. Clin Neurosci 3: 81–88.
57. Chua SE, Murray RM (1996) The neurodevelopmental theory of schizophre-
nia: evidence concerning structure and neuropsychology. Ann Med 28:
547–555.
58. Beckmann H (1999) Developmental malformations in cerebral structures of
schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 249 Suppl 4: 44–47.
59. Cheung V, Cheung C, McAlonan GM, Deng Y, Wong JG, et al. (2008) A
diffusion tensor imaging study of structural dysconnectivity in never-medicated,
first-episode schizophrenia. Psychol Med 38: 877–885.
60. Hoptman MJ, Ardekani BA, Butler PD, Nierenberg J, Javitt DC, et al. (2004)
DTI and impulsivity in schizophrenia: a first voxelwise correlational analysis.
Neuroreport 15: 2467–2470.
61. Chua SE, Lam IW, Tai KS, Cheung C, Tang WN, et al. (2003) Brain
morphological abnormality in schizophrenia is independent of country of
origin. Acta Psychiatr Scand 108: 269–275.
62. Chua SE, Lam IW, Chen EY, Lee PW, Lieh-Mak F, et al. (2002) Asymmetric
lateral ventricular enlargement in Chinese with 1st episode schizophrenia.
Schizophr Res 57: 123–124.
63. Beltinger C, Saule H (1988) Sonography of subependymal cysts in congenital
rubella syndrome. Eur J Pediatr 148: 206–207.
64. Yamashita Y, Fujimoto C, Nakajima E, Isagai T, Matsuishi T (2003) Possible
association between congenital cytomegalovirus infection and autistic disorder.
J Autism Dev Disord 33: 455–459.
65. Fatemi SH, Reutiman TJ, Folsom TD, Huang H, Oishi K, et al. (2008)
Maternal infection leads to abnormal gene regulation and brain atrophy in
mouse offspring: Implications for genesis of neurodevelopmental disorders.
Schizophr Res 99: 56–70.
66. Fatemi SH, Reutiman TJ, Folsom TD, Sidwell RW (2008) The role of
cerebellar genes in pathology of autism and schizophrenia. Cerebellum.
67. Sanjuan J, Tolosa A, Gonzalez JC, Aguilar EJ, Perez-Tur J, et al. (2006)
Association between FOXP2 polymorphisms and schizophrenia with auditory
hallucinations. Psychiatr Genet 16: 67–72.
68. Gong X, Jia M, Ruan Y, Shuang M, Liu J, et al. (2004) Association between the
FOXP2 gene and autistic disorder in Chinese population. Am J Med
Genet B Neuropsychiatr Genet 127B: 113–116.
69. Turetsky BI, Moberg PJ, Mozley LH, Moelter ST, Agrin RN, et al. (2002)
Memory-delineated subtypes of schizophrenia: relationship to clinical,
neuroanatomical, and neurophysiological measures. Neuropsychology 16:
481–490.
70. Kesner RP, Giles R (1998) Neural circuit analysis of spatial working memory:
role of pre- and parasubiculum, medial and lateral entorhinal cortex.
Hippocampus 8: 416–423.
71. Galani R, Obis S, Coutureau E, Jarrard L, Cassel JC (2002) A comparison of
the effects of fimbria-fornix, hippocampal, or entorhinal cortex lesions on
spatial reference and working memory in rats: short versus long postsurgical
recovery period. Neurobiol Learn Mem 77: 1–16.
72. Hazlett EA, Buchsbaum MS, Zhang J, Newmark RE, Glanton CF, et al. (2008)
Frontal-striatal-thalamic mediodorsal nucleus dysfunction in schizophrenia-
spectrum patients during sensorimotor gating. Neuroimage 42: 1164–1177.
73. Swerdlow NR, Lipska BK, Weinberger DR, Braff DL, Jaskiw GE, et al. (1995)
Increased sensitivity to the sensorimotor gating-disruptive effects of apomor-
phine after lesions of medial prefrontal cortex or ventral hippocampus in adult
rats. Psychopharmacology (Berl) 122: 27–34.
74. Japha K, Koch M (1999) Picrotoxin in the medial prefrontal cortex impairs
sensorimotor gating in rats: reversal by haloperidol. Psychopharmacology (Berl)
144: 347–354.
75. Kumari V, Fannon D, Geyer MA, Premkumar P, Antonova E, et al. (2008)
Cortical grey matter volume and sensorimotor gating in schizophrenia. Cortex
44: 1206–1214.
76. Esterberg ML, Trotman HD, Brasfield JL, Compton MT, Walker EF (2008)
Childhood and current autistic features in adolescents with schizotypal
personality disorder. Schizophr Res 104: 265–273.
77. Ghaziuddin M (2005) A family history study of Asperger syndrome. J Autism
Dev Disord 35: 177–182.
78. Craig JS, Hatton C, Craig FB, Bentall RP (2004) Persecutory beliefs,
attributions and theory of mind: comparison of patients with paranoid
delusions, Asperger’s syndrome and healthy controls. Schizophr Res 69: 29–33.
79. Rausch JL, Sirota EL, Londino DL, Johnson ME, Carr BM, et al. (2005)
Open-label risperidone for Asperger’s disorder: negative symptom spectrum
response. J Clin Psychiatry 66: 1592–1597.
80. McAlonan GM, Daly E, Kumari V, Critchley HD, van Amelsvoort T, et al.
(2002) Brain anatomy and sensorimotor gating in Asperger’s syndrome. Brain
125: 1594–1606.
81. Perry W, Minassian A, Lopez B, Maron L, Lincoln A (2007) Sensorimotor
gating deficits in adults with autism. Biol Psychiatry 61: 482–486.
82. Ornitz EM, Lane SJ, Sugiyama T, de Traversay J (1993) Startle modulation
studies in autism. J Autism Dev Disord 23: 619–637.
83. Nopoulos PC, Ceilley JW, Gailis EA, Andreasen NC (1999) An MRI study of
cerebellar vermis morphology in patients with schizophrenia: evidence in
support of the cognitive dysmetria concept. Biol Psychiatry 46: 703–711.
84. Pierce K, Courchesne E (2001) Evidence for a cerebellar role in reduced
exploration and stereotyped behavior in autism. Biol Psychiatry 49: 655–664.
85. McAlonan GM, Cheung V, Cheung C, Suckling J, Lam GY, et al. (2005)
Mapping the brain in autism. A voxel-based MRI study of volumetric
differences and intercorrelations in autism. Brain 128: 268–276.
86. Bailey AJ (1993) The biology of autism. Psychol Med 23: 7–11.
87. Bauman ML, Kemper TL (2003) The neuropathology of the autism spectrum
disorders: what have we learned? Novartis Found Symp 251: 112–122;
discussion 122–118, 281–197.
88. Carper RA, Courchesne E (2000) Inverse correlation between frontal lobe and
cerebellum sizes in children with autism. Brain 123 (Pt 4): 836–844.
89. Bauman ML, Kemper TL (2005) Neuroanatomic observations of the brain in
autism: a review and future directions. Int J Dev Neurosci 23: 183–187.
90. Shi L, Smith SE, Malkova N, Tse D, Su Y, et al. (2009) Activation of the
maternal immune system alters cerebellar development in the offspring. Brain
Behav Immun 23: 116–123.
91. Meyer U, SpoerrI E, Yee B, Schwarz MJ, Feldon J (2008) Evaluating Early
Preventive Antipsychotic and Antidepressant Drug Treatment in an Infection-
Based Neurodevelopmental Mouse Model of Schizophrenia. Schizophrenia
Bulletin.
92. Chance SA, Esiri MM, Crow TJ (2003) Ventricular enlargement in
schizophrenia: a primary change in the temporal lobe? Schizophr Res 62:
123–131.
93. Dorr AE, Lerch JP, Spring S, Kabani N, Henkelman RM (2008) High
resolution three-dimensional brain atlas using an average magnetic resonance
image of 40 adult C57Bl/6J mice. Neuroimage 42: 60–69.
94. Chan E, Kovacevic N, Ho SK, Henkelman RM, Henderson JT (2007)
Development of a high resolution three-dimensional surgical atlas of the
murine head for strains 129S1/SvImJ and C57Bl/6J using magnetic resonance
imaging and micro-computed tomography. Neuroscience 144: 604–615.
95. Ashburner J, Friston KJ (1999) Nonlinear spatial normalization using basis
functions. Hum Brain Mapp 7: 254–266.
96. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, et al.
(2004) Advances in functional and structural MR image analysis and
implementation as FSL. Neuroimage 23 Suppl 1: S208–219.
97. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, et al. (2001) A
voxel-based morphometric study of ageing in 465 normal adult human brains.
Neuroimage 14: 21–36.
98. Dice LR (1945) Measures of the amount of ecologic association between
species. Ecology 26: 297–301.
99. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse
inhibition of startle: normal subjects, patient groups, and pharmacological
studies. Psychopharmacology (Berl) 156: 234–258.
100. Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, et al. (2006)
Startle gating deficits in a large cohort of patients with schizophrenia:
relationship to medications, symptoms, neurocognition, and level of function.
Arch Gen Psychiatry 63: 1325–1335.
101. Pietropaolo S, Singer P, Feldon J, Yee BK (2008) The postweaning social
isolation in C57BL/6 mice: preferential vulnerability in the male sex.
Psychopharmacology (Berl) 197: 613–628.
Prenatal Risk in Schizophrenia
PLoS ONE | www.plosone.org 9 July 2009 | Volume 4 | Issue 7 | e6354
